We are live on ! Find out more
MDWD icon

MediWound

21 hedge funds and large institutions have $26.4M invested in MediWound in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,340% more capital inflows, than outflows

Capital inflows: $15.8M | Capital outflows: $1.1M

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

11% more funds holding

Funds holding: 19 → 21 (+2)

6.9% more ownership

Funds ownership: 14.02% → 20.92% (+6.9%)

Holders
21
Holders Change
+2
Holders Change %
+10.53%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MDWD Hedge Fund Activity: Q1 2023 in Review

21 of the 6,289 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q1 2023, worth a combined $26.4M — up 141% from $11M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MDWD positions and 4 closed out — a net gain of 2 holders — while 8 added to existing stakes and 6 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $10.4M. The largest seller was Meitav Investment House, cutting an estimated $523K.

  • 21 institutional investors held MediWound (MDWD) as of Q1 2023, up from 19 in Q4 2022.
  • Funds reported $26.4M of MediWound stock for Q1 2023, up 141% quarter-over-quarter.
  • 6 funds opened new MediWound positions in Q1 2023 and 4 closed out, a net change of +2 holders.
  • The largest MediWound buyer in Q1 2023 was Point72 Asset Management, an estimated $10.4M added.
  • The largest MediWound seller in Q1 2023 was Meitav Investment House, an estimated $523K sold.

Based on aggregated 13F filings for Q1 2023.